Thursday, April 17, 2014

Daily News: Reuters Health News Headlines - Lowe's to pay $500,000 in EPA lead paint settlement

Thursday, Apr 17, 2014 12:17 PM PDT
Today's Reuters Health News Headlines - Yahoo News:

Lowe's to pay $500,000 in EPA lead paint settlement 
Thursday, Apr 17, 2014 12:17 PM PDT
A view of the sign outside the Lowes store in WestminsterBy Julia Edwards WASHINGTON (Reuters) - Lowe's Home Centers, the No. 2 U.S. home improvement retail chain, has agreed to pay a $500,000 penalty for violating federal rules governing lead paint exposure, U.S. authorities said on Thursday. The Environmental Protection Agency and the Department of Justice said Lowe's had also agreed to implement a new compliance program at more than 1,700 stores nationwide. Lead exposure can cause a range of health problems, from behavioral disorders and learning disabilities to seizures and death. Lead-based paint was banned in the United States in 1978 but remains in many older homes and apartments.
Full Story
Top
Info may prompt seniors to taper off sleeping pills 
Thursday, Apr 17, 2014 12:15 PM PDT
By Anne Harding NEW YORK (Reuters Health) - Older people are willing and able to get themselves off medications like sleeping pills once they're informed of the potential harms, according to a new Canadian study. "Even among patients who have been taking sleeping pills for 30 years, many of them in their 80s and 90s were able to get off the sleeping pills once they realized that these pills could cause falls, memory problems and car accidents," lead author Dr. Cara Tannenbaum of the University of Montreal told Reuters Health. While Valium, Xanax and similar medications, known as benzodiazepines, are not recommended for older adults given such risks, up to one-third of older adults still take them, usually to treat insomnia or anxiety, according to Tannenbaum and her colleagues. Doctors know about the dangers these drugs pose to their patients, the investigators write in JAMA Internal Medicine, but nearly half say they renew benzodiazepine prescriptions for their older patients anyhow, "citing patient dependence and benefit as justifications." Tannenbaum's team wanted to see whether educating older patients taking benzodiazepines about the risks would be an effective way to encourage some to stop using the drugs.
Full Story
Top
Illinois investigates Herbalife as federal, state probes grow 
Thursday, Apr 17, 2014 12:07 PM PDT
An Herbalife logo is shown on a poster at a clinic in the Mission District in San FranciscoBy Svea Herbst-Bayliss BOSTON (Reuters) - Illinois Attorney General Lisa Madigan's office said on Thursday it is investigating Herbalife, joining other state and federal probes of allegations that the weight loss and nutrition company is running a pyramid scheme. Madigan's office was urged to look into the company months ago by civil rights groups, which claimed it was a pyramid scheme targeting minorities. Hedge fund manager William Ackman was the first to call Herbalife a fraud and placed a $1 billion bet against the company in 2012. The company denies the allegations, and high-profile investors such as Carl Icahn, George Soros and Dan Loeb have supported the company in the past by taking stakes.
Full Story
Top
Merck's ragweed pollen allergy drug gets U.S. approval 
Thursday, Apr 17, 2014 12:03 PM PDT
A view shows the U.S. Food and Drug Administration (FDA) logo at its headquarters in Silver Spring(Reuters) - The U.S. Food and Drug Administration has approved Merck & Co's pollen allergy drug Ragwitek. The tablet, which is administered by placing it under the tongue, is to treat the short ragweed pollen induced allergic rhinitis. Merck's Ragwitek will compete with Stallergenes SA's immunotherapy treatment for five types of grass pollen, which was approved by the FDA earlier this month.
Full Story
Top
About 12 million U.S. outpatients misdiagnosed annually : study 
Thursday, Apr 17, 2014 11:54 AM PDT
Devices used to take blood pressure, temperature, and examine eyes and ears rest on a wall inside of a doctor's office in New YorkRoughly 12 million adults who visit U.S. doctors' offices and other outpatient settings, or one in 20, are misdiagnosed every year, a new study has found, and half of those errors could lead to serious harm. The study by a team of Texas-based researchers attempted to estimate how often diagnostic errors occur in outpatient settings such as doctors' offices and clinics, as exact figures don't exist. Efforts to improve patient safety have largely focused on inpatient hospital care, including programs introduced by President Barack Obama's Affordable Care Act, even though most diagnoses are made in outpatient clinics, the study said. "It's important to outline the fact that this is a problem," said Dr. Hardeep Singh, the study's lead author and a patient safety researcher at Baylor College of Medicine in Houston and at the Michael E. DeBakey VA Medical Center, also in Houston.
Full Story
Top
UnitedHealth: New hepatitis C drug costs far more than forecast 
Thursday, Apr 17, 2014 11:29 AM PDT
A man looks over the Affordable Care Act signup page on the HealthCare.gov website in New York in this photo illustrationUnitedHealth Group Inc, the largest U.S. health insurer, said it spent more than $100 million to cover a pricey new hepatitis C drug from Gilead Sciences Inc in its first three months on the market, an amount that was "multiple" times what it had expected. UnitedHealth is the first insurer to quantify its costs to cover patients using Gilead's new Sovaldi treatment, whose $84,000 price tag has spurred a national outcry over the rising costs of specialty medicines. UnitedHealth shares fell nearly 4 percent on Thursday and shares of rivals WellPoint Inc and Aetna Inc fell 3.8 percent and 3.4 percent, respectively, as investors weighed what their potential costs could be as well. Sovaldi has been shown to cure most patients of the liver-wasting virus with few side effects, but health officials, insurers and Medicaid directors are balking at the cost.
Full Story
Top
'X-Men' director Bryan Singer accused of drugging, raping teen 
Thursday, Apr 17, 2014 11:14 AM PDT
Director of the movie Singer poses at the premiere of "Jack the Giant Slayer" in Hollywood, CaliforniaBy Eric Kelsey LOS ANGELES (Reuters) - A director of the popular "X-Men" films, Bryan Singer, has been accused of drugging and raping a teenage boy in California and Hawaii in the late 1990s, according to a lawsuit filed in U.S. court. The lawsuit filed on Wednesday, just weeks before the release of Singer's upcoming "X-Men: Days of Future Past," alleges the 48-year-old used his influence as a Hollywood insider as well as a range of drugs and alcohol to force anal and oral sex on the boy. Michael Egan seeks unspecified damages and a jury trial after wide-ranging abuses at California and Hawaii house parties beginning in the late 1990s, according to the civil action filed in Hawaii federal court. Singer's attorney, Marty Singer, did not immediately respond to requests for comment.
Full Story
Top
Brutish and short? DNA 'switch' sheds light on Neanderthals 
Thursday, Apr 17, 2014 11:02 AM PDT
To match Reuters Life! NEANDERTHAL-CROATIA/MUSEUMHundreds of Neanderthals' genes were turned off while the identical genes in today's humans are turned on, the international team announced in a paper published online in Science. They also found that hundreds of other genes were turned on in Neanderthals, but are off in people living today. Among the hundreds: genes that control the shape of limbs and the function of the brain, traits where modern humans and Neanderthals differ most. "People are fundamentally interested in what makes us human, in what makes us different from Neanderthals," said Sarah Tishkoff, an expert in human evolution at the University of Pennsylvania, who was not involved in the new study.
Full Story
Top
Obama budget would boost U.S. tax revenue, cut deficits: CBO 
Thursday, Apr 17, 2014 10:59 AM PDT
Obama speaks after touring the Community College of Allegheny West Hills Center in Oakdale, PennsylvaniaBy David Lawder WASHINGTON (Reuters) - President Barack Obama's fiscal 2015 budget request would boost U.S. tax revenue by nearly $1.4 trillion over 10 years if fully enacted, slashing deficits by $1.05 trillion while funding new spending, the Congressional Budget Office said on Thursday. The likelihood that Congress will advance Obama's plan in its entirety is virtually nil, but the CBO's latest analysis will feed campaign messaging by Democrats and Republicans ahead of congressional elections in November. The analysis by the nonpartisan agency compares Obama's request with a new CBO "baseline" estimate released last week that assumes no changes to current tax and spending laws. But Obama's budget plan is loaded with policy changes, including an assumption that sweeping immigration reforms will be enacted, producing a net 10-year deficit reduction of $158 billion.
Full Story
Top
California sees Obamacare surge as open enrollment ends for 2014 
Thursday, Apr 17, 2014 10:48 AM PDT
A man looks over the Affordable Care Act signup page on the HealthCare.gov website in New York in this photo illustrationThanks to a final April surge, California's Obamacare marketplace enrolled a total of 1.4 million people in private health insurance plans, state officials announced on Thursday, beating a federal forecast by just over 800,000 enrollees. California's Obamacare enrollments are among 7.5 million people nationally who have signed up, according to federal officials. Peter V. Lee, executive director of Covered California, the state's Obamacare health insurance marketplace, called that "a huge number" and said enrollees "are part of history." The country's first open enrollment period for coverage under President Barack Obama's healthcare reform law ended in most states on March 31. California and a handful of others kept their doors open longer, citing technical difficulties that kept some customers from accessing Obamacare websites.
Full Story
Top
Wall Street edges higher during earnings flurry 
Thursday, Apr 17, 2014 10:41 AM PDT
Traders work on the floor of the New York Stock ExchangeBy Rodrigo Campos NEW YORK (Reuters) - Stocks advanced slightly in choppy trading on Thursday after three days of gains, as underwhelming results from tech bellwethers Google and IBM were offset by upbeat quarterly numbers, including those from Morgan Stanley and General Electric. The latest data showed the U.S. economy's health was improving. The combined reported and expected earnings-per-share growth estimate for S&P 500 components rose to 1.7 percent from Wednesday's 0.6 percent, Thomson Reuters data showed, indicating most companies that reported results in the past 24 hours exceeded expectations. The technology sector capped the S&P 500's gain, with Google shares down 3.2 percent at $545.81 and IBM off 3.2 percent at $190.28 after both reported earnings late Wednesday that failed to impress Wall Street.
Full Story
Top
Church must be open to sick, homeless, pope says on Holy Thursday 
Thursday, Apr 17, 2014 10:12 AM PDT
Pope Francis blows on blessed Chrism oil as he celebrates the Chrism Mass in Saint Peter's Basilica at the VaticanBy Philip Pullella VATICAN CITY (Reuters) - Pope Francis, starting four packed days culminating in Easter, said the Catholic Church must always be a refuge for the needy and later washed the feet of 12 disabled people at a traditional Holy Thursday ceremony. In the morning, Francis, who regularly urges priests to shun material comforts or the desire to climb clerical career ladders, led the first of two solemn services on the day that Christians commemorate the founding of the priesthood by Jesus. In the grandeur of St. Peter's Basilica, he celebrated a "Mass of the Chrism" during which he and priests renewed the vows they took on the day of their ordination and he blessed oils to be used in administering sacraments during the year.
Full Story
Top
GE industrial profit boost underscores strategy, shares up 
Thursday, Apr 17, 2014 09:46 AM PDT
A GE logo is seen in a store in Santa MonicaGeneral Electric Co posted a 12 percent rise in overall industrial profits on Thursday, as strength in its businesses selling gas turbines, jet engines and oil industry equipment offset weakness in healthcare and transportation. "The big story is the organic revenue growth," said Tim Ghriskey, chief investment officer of Solaris Asset Management, which owns GE shares. "It really shows the return to an industrial emphasis is paying off, and where the company is focusing." The results underscored GE Chief Executive Officer Jeff Immelt's strategy to focus the company even more on manufacturing of large industrial products as he reduces the company's dependence on its GE Capital finance unit. Immelt is also seeking to improve profit margins and slash administrative costs at the 307,000-employee company.
Full Story
Top
West African Ebola outbreak caused by new strain of disease: study 
Thursday, Apr 17, 2014 09:30 AM PDT
By Saliou Samb CONAKRY (Reuters) - An Ebola outbreak blamed for 135 deaths in West Africa in the past month was not imported from Central Africa but caused by a new strain of the disease, a study in a U.S. medical journal said, raising the specter of further regional epidemics. The spread of Ebola from a remote corner of Guinea to the capital and into neighboring Liberia, the first deadly outbreak reported in West Africa, has caused panic across a region struggling with weak healthcare systems and porous borders. Ebola is endemic to Democratic Republic of Congo, Uganda, South Sudan and Gabon, and scientists initially believed that Central Africa's Zaire strain of the virus was responsible for the outbreak.
Full Story
Top
In a cloning first, scientists create stem cells from adults 
Thursday, Apr 17, 2014 09:03 AM PDT
By Sharon Begley NEW YORK (Reuters) - Scientists have moved a step closer to the goal of creating stem cells perfectly matched to a patient's DNA in order to treat diseases, they announced on Thursday, creating patient-specific cell lines out of the skin cells of two adult men. The advance, described online in the journal Cell Stem Cell, is the first time researchers have achieved "therapeutic cloning" of adults. Technically called somatic-cell nuclear transfer, therapeutic cloning means producing embryonic cells genetically identical to a donor, usually for the purpose of using those cells to treat disease. But nuclear transfer is also the first step in reproductive cloning, or producing a genetic duplicate of someone - a technique that has sparked controversy since the 1997 announcement that it was used to create Dolly, the clone of a ewe.
Full Story
Top

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.

No comments:

Post a Comment